Our Autoimmune and Cholestatic Liver Disease Program consists of dedicated experts and support staff committed to providing cutting-edge care and innovative research to patients with disorders including Autoimmune Hepatitis (AIH), Primary Biliary Cholangitis (PBC), and Primary Sclerosing Cholangitis (PSC). Other conditions that we treat include sarcoidosis, autoimmune mediated liver injury, cholestasis of unknown etiology, lupus, cholangitis, primary biliary cholangitis, secondary cholangitis, and overlap syndromes.
The program offers effective and personalized treatment for patients with these rare liver diseases. Our doctors are specialists in these conditions, with special expertise in interpreting biopsy scans, medications, and more. Patients also have access to our clinical research, any of which offers new treatment options otherwise unavailable to the general public.
We are partnered with the Yale School of Medicine Liver Center, one of only four NIH-sponsored liver research centers in the United States, and the only center in Connecticut that offers comprehensive patient care for individuals with autoimmune and cholestatic liver diseases.